# Duloxetine Delayed-Release

NDC: 71610-218
Generic name: DULOXETINE HYDROCHLORIDE
Labeler / Manufacturer: Aphena Pharma Solutions - Tennessee, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, DELAYED RELEASE PELLETS
Routes: ORAL
Marketing started: 20140611

FDA application: ANDA203088

## Active ingredients

- DULOXETINE HYDROCHLORIDE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71610-218"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71610-218
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db686a0a-9b2a-4017-8bd1-b981da47c2f3